Brad Kline

Brad Kline, Ph.D. is the Senior Director of Research and Development at Navrogen Inc.  Prior to joining the Navrogen team, he was responsible for overseeing antibody discovery and development at Morphotek Inc. During his tenure at Morphotek, he oversaw the engineering and development of several experimental antibodies that advanced to clinical trials as well as published on the underlying biological mechanisms of humoral immuno-suppression. Brad is a trained molecular biologist and immunologist with over 25 peer-reviewed scientific papers in the fields of antibody engineering, oncology, and immunology and an inventor several issued patents covering antibody engineering, antibody therapeutics and disease-target discovery.

Brad received a B.A. in Biology from the University of Virginia, a Ph.D. in Microbiology and Immunology from the University of Miami, and a post-doctoral fellowship in molecular endocrinology at the University of Pennsylvania.